Shi-Juan Mai (Shijuan Mai)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Endoplasmic Reticulum

Reactive Oxygen Species

Signaling Pathway

Top Venues

Medical oncology (Northwood, London, England)

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Ting Yin, Lu Shi, Chun Wu, Mei-Yin Zhang, Jia-Xin Li, Yu-Feng Zhou, Shuo-Cheng Wang, Hui-Yun Wang, Shi-Juan Mai
TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma. Medical oncology (Northwood, London, England) 41 (3) (2024)
Yu-Ting Yin, Lu Shi, Chun Wu, Mei-Yin Zhang, Jia-Xin Li, Yu-Feng Zhou, Shuo-Cheng Wang, Hui-Yun Wang, Shi-Juan Mai
TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma. Medical oncology (Northwood, London, England) 41 (3) (2024)
Yu-Ting Yin, Lu Shi, Chun Wu, Mei-Yin Zhang, Jia-Xin Li, Yu-Feng Zhou, Shuo-Cheng Wang, Hui-Yun Wang, Shi-Juan Mai
TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma. Medical oncology (Northwood, London, England) 41 (3) (2024)
Yu-Ting Yin, Lu Shi, Chun Wu, Mei-Yin Zhang, Jia-Xin Li, Yu-Feng Zhou, Shuo-Cheng Wang, Hui-Yun Wang, Shi-Juan Mai
TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma. Medical oncology (Northwood, London, England) 41 (3) (2024)
Yuting Yin, Chun Wu, Yufeng Zhou, Meiyin Zhang, Shi-Juan Mai, Minshan Chen, Hui-Yun Wang
Ezetimibe Induces Paraptosis through Niemann-Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells. Genes 15 (1) (2023)
Yuting Yin, Chun Wu, Yufeng Zhou, Meiyin Zhang, Shi-Juan Mai, Minshan Chen, Hui-Yun Wang
Ezetimibe Induces Paraptosis through Niemann-Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells. Genes 15 (1) (2023)
Yuting Yin, Chun Wu, Yufeng Zhou, Meiyin Zhang, Shi-Juan Mai, Minshan Chen, Hui-Yun Wang
Ezetimibe Induces Paraptosis through Niemann-Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells. Genes 15 (1) (2023)
Yuting Yin, Chun Wu, Yufeng Zhou, Meiyin Zhang, Shi-Juan Mai, Minshan Chen, Hui-Yun Wang
Ezetimibe Induces Paraptosis through Niemann-Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells. Genes 15 (1) (2023)
Chun Wu, Lianhui Duan, Hongmu Li, Xuefei Liu, Taonong Cai, Yang Yang, Yuting Yin, Wuguang Chang, Leqi Zhong, Lin Zhang, Yixin Cheng, Haide Qin, Zhesheng Wen, Huiyun Wang, Shi-Juan Mai
PD1 hi CD200 hi CD4 + exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer. Clinical and translational medicine 13 (6) (2023)
Chun Wu, Hongmu Li, Wuguang Chang, Leqi Zhong, Lin Zhang, Zhesheng Wen, Shi-Juan Mai
Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma. Genes 13 (11) (2022)